Vanda Pharmaceuticals Inc News - VNDA

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan PR Newswire WASHINGTON, April 17, 2024...

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak PR...

Biotech Catches Major Premarket Bid Following FDA Approval

A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA...

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia PR...

Form 144 - Report of proposed sale of securities

Tiger Money 10 hours ago

Agreed. This could double quickly

👍️0

philaya 12 hours ago

got this today...
very good trades.

👍️0

harry crumb 2 days ago

This little gem could run up fast, they obviously have their science going in the right direction as the offers are there just not the price, could be a 10.00 offer in the works

👍️0

morokoy 2 days ago

Shares Outstanding 57,537,499 shares
Insider Shares 7,908,897 shares
Insider Ownership 13.75 %
Total Insiders 34

👍️0

morokoy 2 days ago

"The dividend distribution of rights will be payable to stockholders of record as of the close of business on April 29, 2024."

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends.

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends. You should receive a Form 1099-DIV, Dividends and Distributions from each payer for distributions of at least $10.

Guess we'll have to wait on the promised 8K.

Additional details of the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The filing will be available on the SEC's website at www.sec.gov.

👍️0

harry crumb 3 days ago

Minimum 8$ imo

👍️0

MiamiGent 3 days ago

Vanda Pharmaceuticals rejects takeover proposal from Future Pak
REUTERS
1 mins ago
April 17 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.NaE) on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues the company.

(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)

👍️0

Monksdream 3 days ago

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

👍️ 1

MiamiGent 3 days ago

Probably...but I took it at 5.49

👍️0

Monksdream 3 days ago

Will it grow legs after 9:30

👍️0

MiamiGent 3 days ago

VNDA Vol picking up..

$5.49 +$1.44 (+35.56%)

Volume 3,354,569

90 DAV... 2M

👍️0

MiamiGent 3 days ago

VNDA Here we go
$5.3781 +$1.3281 (32.79%)

Bid ARCX
5.36 x 10
Ask XNMS
5.38 x 11
Volume
2,971,106

👍️0

MiamiGent 3 days ago

VNDA Vol is good. Already @ 90 DAV
Volume 2,056,421
10/90-day avg. volume
7M / 2M

👍️0

MiamiGent 3 days ago

VNDA Good post, Laster.
https://www.futurepak.com/

👍️0

Laster 3 days ago

The major question is who is Future Pak really?
Is this a legit offer?
Either way, company is extremely undervalued with no debt (I believe) and lots of cash.
Large short position. Lots of selling PM at $5.
Market does not seem to believe this offer. Sorry.

👍️0

MiamiGent 3 days ago

VNDA Float 52.05M

Shares Short (3/28/2024) 2.49M
Short Ratio (3/28/2024) 2.78
Short % of Float (3/28/2024) 5.45%

👍️0

MiamiGent 3 days ago

VNDA
Bid EDGX
4.85 x 3
Ask EDGX
4.88 x 3

Volume
1,790,654
Avg Vol (10 day) 6.63M

👍️0

MiamiGent 3 days ago

Vanda Pharmaceuticals
Closed .01 (-0.25%)

Pre-market
$5.15 +1.10 (+27.16%)
As of Apr-17-2024 7:23:52 AM ET
Bid x size $5.14 x 1
Ask x size $5.16 x 3

👍️0

MiamiGent 3 days ago

VNDA In 5.12. Let's see, said the blind man.

👍️0

MiamiGent 3 days ago

Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
Apr. 17, 2024 6:41 AM ETVanda Pharmaceuticals Inc. (VNDA) Stock

Monksdream 3 days ago

Will it grow legs after 9:30

👍️0

Monksdream 2 weeks ago

Will it grow legs after 9:30

👍️0

tknuncle 2 months ago

I have been acquiring since $3.90. I wish that I would have waited longer lol but, like what I see with VNDA. Was going to grab the last of my starter position soon. GLTA

👍️0

weedtrader420 3 months ago

FDA Approve

👍️0

Triple nickle 5 months ago

Fda accepts new drug application for tradipitant in the after hours today

👍️ 1

jgrabar 2 years ago

$VNDA -On May 19, 2022, Vanda Pharmaceuticals agreed to settle a securities fraud class action complaint (the “Complaint”) for $11.5 Million. https://grabarlaw.com/the-latest/vanda-pharmaceuticals-investigation/

👍️0

RNsidersbuying 3 years ago

VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen

👍️0

XenaLives 4 years ago

Everything would be a lot better if the govt. would just let doctors treat COVID like another flu bug. The drama is getting old.

👍️0

Peepson 4 years ago

Yo, this thing is going to trade sideways for a while. They have a drug that could help with covid but so does every other pharma company. Its a safe hold imo but nothing will happen fast i don't think

👍️0

XenaLives 4 years ago

What's up? Doesn't seem to be much interest. I was looking at the chart but haven't found much on the company yet.

👍️0

otcmoneydoubler 4 years ago

LOL. VNDA GOT NEWS TODAY. SO WHAT DD HAVE YOU GOT TO SHARE?

👍️0

Peepson 4 years ago

Yo, does anyone still follow this board. I might have some interesting dd to share.

👍️0

bezen 7 years ago

https://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html

👍️0

Coz Mabluda 7 years ago

Brett Jensen. SA article re VNDA. Expects positive analyst's review.

Vanda Pharmaceuticals (NASDAQ:VNDA) posted solid third quarter results on Thursday. Instead of losing a dime a share as expected, the company posted a profit of 11 cents a share. Revenue was also up more than 35% from the same period a year ago. The company now looks like it could be profitable in FY2017. I expect some positive analyst commentary on this name by analysts over the next week. Vanda has a solid pipeline and over $140 million in cash and marketable securities on the balance sheet. One has to like the company's growth trajectory and the concern seems undervalued with just a $600 million market capitalization.

👍️0

stocktrademan 8 years ago

fast and steady profit scan VNDA bullish 16.64

normal chart

log chart

👍️0

ClearlyStocks 8 years ago

VNDA $16.74

👍️0

ClearlyStocks 8 years ago

$VNDA $16 from $14 now

👍️0

nyctraydr 8 years ago

Where Things Stand For Vanda Pharmaceuticals In Fanapt Patent Suit http://marketexclusive.com/things-stand-vanda-pharmaceuticals-inc-nasdaqvnda-fanapt-patent-suit/24951/?icd1

👍️0

ClayTrader 8 years ago

* * $VNDA Video Chart 08-25-16 * *

Link to Video - click here to watch the technical chart video

👍️0

ClearlyStocks 8 years ago

$15.24 weeee

👍️0

ClearlyStocks 8 years ago

$14.60

👍️0

ClearlyStocks 8 years ago

$14.22

👍️0

ClearlyStocks 8 years ago

$14 wow

👍️0

GREEN MAKER 8 years ago

Approved!!!!!

👍️0

jaytea 8 years ago

VNDA PDUFA Friday:

The FDA has set a user fee goal date under the Prescription Drug User Fee Act of May 27, 2016, which is the target date for the FDA to complete its review of the sNDA.

👍️0

jaytea 8 years ago

VNDA breaks above 200 day MA

👍️0

jaytea 8 years ago

Moving up nicely this morning.

👍️0

Ppower 9 years ago

Nice been following this stock for awhile now and made some good money here.

Also, follow Titan Pharmaceuticals TTNP

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Vanda Pharmaceuticals Inc (VNDA)

Get an advanced news scanner tailored to your needs by ADVFN

VNDA News

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Biotech Catches Major Premarket Bid Following FDA Approval

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

VNDA Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Vanda Pharmaceuticals Inc (VNDA) News

Vanda Pharmaceuticals Inc (VNDA)

Get an advanced news scanner tailored to your needs by ADVFN

VNDA News

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Biotech Catches Major Premarket Bid Following FDA Approval

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

VNDA Discussion

Your Recent History

Company

Business

Popular

Get The App